MAPT and neurodegenerative disease: The failure of degradative pathways such as the ubiquitin proteasome system or the autophagy-lysosomal pathway (ALP) to clear the pathogenic forms of Tau participates in the pathogenesis of neurodegenerative diseases (Chesser et al., 2013; Fleming et al., 2022).